Clinical Trial

Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

Study acronym: RESTORE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A multicenter prospective modified platform trial evaluating several cellular, acellular, and matrix like products and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Trial Details
NCT Number NCT07665268
Lead Sponsor Sequence LifeScience, Inc.
Collaborators: Serena Group
Conditions Skin Ulcer, Pressure Ulcer (PU), Pressure Ulcer of Skin, Pressure Sore, Chronic Ulcer, Pressure Wound
Enrollment 2,000 participants
Start Date 2026-01-28
Primary Completion 2028-01-28 (estimated)
Study Completion 2028-01-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-24